NASDAQ
CTI BioPharma Corp. (CTIC) has a free cash flow growth of -100.50% as of Friday, May 29, 2026. This represents a 818.93% decrease compared to its 12-month average of 13.98%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.